Alvarez & Marsal Private Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alvarez & Marsal Private Wealth Partners's VRTX Position: Q2 2026 in Review
Alvarez & Marsal Private Wealth Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 50% in Q2 2026, selling an estimated $192K and leaving 435 shares worth $216K. The position accounts for 0.03% of the portfolio, ranked #100.
Alvarez & Marsal Private Wealth Partners first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $388K in Q1 2026. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Alvarez & Marsal Private Wealth Partners held 435 shares of Vertex Pharmaceuticals worth $216K as of Q2 2026.
- Alvarez & Marsal Private Wealth Partners sold 434 Vertex Pharmaceuticals shares in Q2 2026, an estimated $192K.
- Vertex Pharmaceuticals made up 0.03% of Alvarez & Marsal Private Wealth Partners's portfolio in Q2 2026, its #100 holding.
- Alvarez & Marsal Private Wealth Partners first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Alvarez & Marsal Private Wealth Partners's Vertex Pharmaceuticals position peaked at $388K in Q1 2026.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Alvarez & Marsal Private Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.